ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 87 filers reported holding ADURO BIOTECH INC in Q4 2016. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $10,500,000 | -5.2% | 844,768 | -13.7% | 0.01% | 0.0% |
| Q2 2016 | $11,073,000 | -26.9% | 979,024 | -17.2% | 0.01% | -30.8% |
| Q1 2016 | $15,151,000 | -69.8% | 1,182,781 | -33.7% | 0.01% | -69.8% |
| Q4 2015 | $50,223,000 | -23.5% | 1,784,751 | -50.0% | 0.04% | +43.3% |
| Q3 2015 | $65,684,000 | – | 3,569,502 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 745,886 | $8,503,000 | 1.71% |
| OAK RIDGE INVESTMENTS LLC | 915,134 | $10,433,000 | 0.34% |
| Rock Springs Capital Management LP | 415,000 | $4,731,000 | 0.32% |
| CLOUGH CAPITAL PARTNERS L P | 326,400 | $3,721,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 53,300 | $608,000 | 0.12% |
| GLOBEFLEX CAPITAL L P | 36,200 | $413,000 | 0.10% |
| Vident Investment Advisory, LLC | 65,874 | $751,000 | 0.09% |
| Virtus ETF Advisers LLC | 23,109 | $263,000 | 0.08% |
| Foundry Partners, LLC | 77,452 | $883,000 | 0.04% |
| Artal Group S.A. | 100,000 | $1,140,000 | 0.02% |